The key factors driving market growth are the growing demand from pharmaceutical industry, rising technological advancements, the huge need for a reduction in production costs and increasing growth in generic medicines and biopharmaceuticals. However, high cost of robots and lack of skilled personnel to work in automated manufacturing units are some of the factors restraining the growth of global pharmaceutical robots market.
The Asia-Pacific is both the dominating and fastest growing market for global pharmaceutical robots during the forecast period 2016-2023, in terms of market revenue share. The increased adoption of robotic machines by the leading pharmaceutical companies headquartered in countries such as Japan and China, and the presence of industrial robotics companies in Asia Pacific, such as Kawasaki Heavy industries, Mitsubishi Electric Corporation, Fanuc Corporation, Denso Wave, etc., are some of the key factors driving the market growth in the Asia-Pacific. Furthermore, additional factors such as increased investments and funding in the robotics technology, and the growing pharmaceutical industry, etc., are expected to positively influence the growth of the Asia-Pacific pharmaceutical robots market.
Read more: http://bit.ly/PharmaRobots